Javitt Jonathan C 13D/13G Filings for NRx Pharmaceuticals, Inc. (NRXP)

Javitt Jonathan C 13D and 13G filings for NRx Pharmaceuticals, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2022-06-17
5:00 pm
Unchanged
2022-06-1313DNRx Pharmaceuticals, Inc.
NRXP
Javitt Jonathan C1,486,833
22.300%
0
(Unchanged)
Filing
2022-06-03
3:59 pm
Sale
2022-06-0113DNRx Pharmaceuticals, Inc.
NRXP
Javitt Jonathan C1,486,833
22.300%
-1,305,168decrease
(-46.75%)
Filing
2021-11-02
4:02 pm
Sale
2021-07-1613DNRx Pharmaceuticals, Inc.
NRXP
Javitt Jonathan C2,792,001
48.190%
-86,919decrease
(-3.02%)
Filing
2021-06-03
5:30 pm
Purchase
2021-05-2413DNRx Pharmaceuticals, Inc.
NRXP
Javitt Jonathan C2,878,919
60.660%
2,878,919increase
(New Position)
Filing